Knight Ridder/Tribune Business News - Drug Firms Settle Lawsuit on Cardizem Generic for $80 Million.
By Julius A. Karash, The Kansas City Star, Mo. Knight Ridder/Tribune Business News
Feb. 19–Aventis Pharmaceuticals and Andrx Corp. have agreed to pay a combined $80 million to settle claims of conspiring to keep a generic form of Cardizem CD off the market.
The money is earmarked for consumers, state agencies and insurance companies that overpaid for the widely used blood pressure medication and its generic equivalents.
Most Popular
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
The Art Of Public Speaking: Build Connection With Your Audience
The antitrust settlement “continues our mission to protect consumers by fighting prescription drug companies’ efforts to manipulate the law to keep …
Read the rest of this article with a Free Trial at HighBeam Research.
